Displaying 2501 - 2520 of 4733
FTC Requires Pfizer Inc. to Sell Rights to Four Products as a Condition of Acquiring Hospira, Inc.
FTC Approves Final Order Preserving Competition in U.S. Markets for Three Orthopedic Medical Products
Zimmer Holdings, Inc. / Biomet, Inc., In the Matter of
Medical device company Zimmer Holdings, Inc. agreed to divest U.S. rights and assets related to unicondylar knee implants, total elbow implants, and bone cement in order to settle FTC charges that its proposed $13.35 billion acquisition of Biomet Inc. is anticompetitive. According to the complaint, Zimmer and Biomet are two of the only three substantial competitors in the U.S. markets for unicondylar knee implants and total elbow implants, and two of only four significant competitors in the U.S. market for bone cement. The order requires Zimmer to divest to Smith & Nephew the U.S. intellectual property, manufacturing technology, and existing inventory relating to its unicondylar knee implant, and to provide transitional services to help them establish manufacturing capabilities and secure necessary FDA approvals. The order also requires Biomet to divest to DJO the U.S. intellectual property, manufacturing technology, and existing inventory relating to its total elbow implant and bone cement products, and it facilitates DJO’s hiring of the Biomet sales representatives and other staff who work with these products.
Pharmaceutical Companies Settle FTC Charges of an Illegal Agreement not to Compete, which Resulted in Higher Prices for Generic Version of ADHD Drug
1508003 Informal Interpretation
FTC Commissioner Joshua D. Wright to Resign
1508004 Informal Interpretation
Daniel Bock, Jr., Plaintiff-Appellee, v. Pressler & Pressler, LLP, Defendant-Appellant
FTC Issues Statement of Principles Regarding Enforcement of FTC Act as a Competition Statute
Federal Trade Commission (Bureau of Competition) and Department of Justice (Antitrust Division): Hart-Scott-Rodino Annual Report: Fiscal Year 2014: Section 7A of the Clayton Act, 15 U.S.C. 18a (The Hart-Scott-Rodino Antitrust Improvements Act of 1976)
FTC Approves Fiscal Year 2014 HSR Premerger Notification Report
1508001 Informal Interpretation
FTC Approves Application from Holcim LTD. and Lafarge S.A. to Divest Cement Assets
FTC Approves Final Order Preserving Competition in U.S. Market for Cigarettes
Reynolds American Inc., and Lorillard, Inc., In the Matter of
Tobacco companies Reynolds American Inc. and Lorillard Inc. agreed to divest four cigarette brands to Imperial Tobacco Group to settle FTC charges that their proposed $27.4 billion merger would likely be anticompetitive. The order requires Reynolds to divest to Imperial four established cigarette brands: Winston, Kool, Salem, and Maverick. Imperial is an international tobacco manufacturer with a competitive presence in about 70 countries, but a comparatively small presence in the United States. With the acquisition of the divested assets, Imperial would become a more substantial competitor in the United States. The Commission’s order requires not only that the brands be divested, but also that Reynolds divest to Imperial the Lorillard manufacturing facilities in Greensboro, North Carolina, and provide Imperial with the opportunity to hire most of the existing Lorillard management, staff, and salesforce. It also requires the newly merged Reynolds and Lorillard to provide Imperial with retail shelf space for a short period, and to provide other operational support during the transition.
Room to Run: Regulatory Responses to Dynamic Changes in the Organization of Work
Displaying 2501 - 2520 of 4733